Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Affymetrix, Inc. and DNA Link, Inc., a Korean genomics-based biotechnology company, have signed a Powered by Affymetrix (PbA) Programme agreement in which DNA Link, Inc. obtains a worldwide license to ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Following the Silicon Valley pattern of jamming more power into less space, Santa Clara's Affymetrix will disclose today that it has packed most of the human genome onto two DNA chips. Previously, ...

Ron Davis and I were studying plant transcription factors in 1990, but progress was slow and arduous because the gene expression tools were so primitive. We conceived of the DNA microarray in 1993 to ...

SANTA CLARA, Calif., Oct. 19, 2006 – Affymetrix Inc. (Nasdaq: AFFX) announced today that researchers at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona have used the ...

The liver is a primary site for metabolism of xenobiotic compounds by enzymes which are dynamically regulated. Gene regulation in the liver also reflects the overall metabolic, energetic and hormonal ...

OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...